التفاصيل البيبلوغرافية
العنوان: |
Clinical and Radiographic Response With Combined BRAF-Targeted Therapy in Stage 4 Ameloblastoma. |
المؤلفون: |
Kaye, Frederic J., Ivey, Alison M., Drane, Walter E., Mendenhall, William M., Allan, Robert W. |
المصدر: |
JNCI: Journal of the National Cancer Institute; Dec2014, Vol. 107 Issue 1, p1-1, 1p |
مصطلحات موضوعية: |
AFRICAN American men, AMELOBLASTOMA, MANDIBLE, ORAL drug administration, FLUORODEOXYGLUCOSE F18, DISEASES |
مستخلص: |
The article focuses on a study involving a 40-year-old African American male diagnosed with stage 4 metastatic ameloblastoma of the left mandible while the presence of a BRAF V600E mutation was detected and a cancer gene profile was obtained. Topics discussed include effects of GlaxoSmithKline oral drugs dabrafenib and trametinib, and fluorodeoxyglucose (FDG) activity. |
قاعدة البيانات: |
Complementary Index |